Obstetrics & Gynecology, Gynecologic Oncology · Tampa, FL
NPI
1629068044
Since 2005
Specialty
Obstetrics & Gynecology, Gynecologic Oncology
Code 207VX0201X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1 Tampa General Cir
Tampa, FL, 33606
Phone (813) 974-2201
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
590 services
Medicare patients, 2024
157
Average age 71
Drug cost, 2024
$3.0M
703 prescriptions
Company payments, 2025
$1,699
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas J Rutherford was code 99214 (office e&m - established), 216 times for 48 patients. In total Thomas J Rutherford billed 590 services in 40 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 216 | 48 | $69.02 | $15K |
| 99213 Office E&M - Established | Facility | 164 | 90 | $44.42 | $7,285 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 74 | 51 | $12.81 | $948 |
| 99231 Hospital E&M - Subsequent | Facility | 29 | 13 | $35.99 | $1,044 |
| 99205 Office E&M - New | Facility | 26 | 26 | $127.25 | $3,308 |
By year: 2022 $73K for 585 services; 2023 $63K for 521 services; 2024 $55K for 590 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas J Rutherford prescribed most often to Medicare patients was Lynparza (Olaparib), with 99 prescriptions and refills. In total Thomas J Rutherford wrote 703 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lynparza Olaparib | 99 | 102 | 13 | $1.4M |
| Ibuprofen Generic | 45 | 45 | 43 | $165 |
| Oxycodone Hcl Generic | 45 | 45 | 44 | $132 |
| Jemperli Dostarlimab-Gxly | 43 | 46 | Under 11 | $535K |
| Dexamethasone Generic | 36 | 36 | 15 | $109 |
| Keytruda Pembrolizumab | 34 | 37 | Under 11 | $441K |
| Eliquis Apixaban | 28 | 30 | 18 | $16K |
| Cisplatin Generic | 28 | 28 | Under 11 | $1,698 |
| Carboplatin Generic | 21 | 21 | Under 11 | $1,374 |
| Paclitaxel Generic | 21 | 21 | Under 11 | $2,600 |
| Gabapentin Generic | 20 | 20 | Under 11 | $87.69 |
| Cyclophosphamide Generic | 19 | 19 | Under 11 | $15K |
| Anastrozole Generic | 18 | 48 | Under 11 | $281 |
| Docetaxel Generic | 18 | 18 | Under 11 | $2,293 |
| Prochlorperazine Maleate Generic | 16 | 16 | 11 | $272 |
Brand drugs: 317 claims; generic drugs: 386 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas J Rutherford $1,699 ($1,699 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $727.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.